Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

NCT: NCT05535738 · ACTIVE_NOT_RECRUITING

NCT IDNCT05535738
StatusACTIVE_NOT_RECRUITING
Start Date2022-11-15
Completion2027-12-31

Brief Summary

The purpose of this study is to answer: how do inflammation and anti-inflammatory skin therapies work in the skin? Inflammation is a protective response from the body's immune system to injury, disease, or irritation. It is a process by which your body's white blood cells and the things they make protect you from infection from outside invaders such as bacteria and viruses.

Frequently Asked Questions

What is Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation?

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation is a clinical trial registered under NCT05535738. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05535738?

The current status of NCT05535738 (Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation) is: ACTIVE_NOT_RECRUITING.

When did Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation start?

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation started on 2022-11-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑